Why Companies With Their Own Plants Still Outsource Pharma Production

Most writing about outsourcing pharma production assumes you have no plant. This page assumes you do — or that you are large enough to build one — and asks the harder question: why do companies that already manufacture keep outsourcing anyway?

Because they all do. Understanding why tells you more about this industry than any argument aimed at startups.

1. You cannot make everything, and it is not a choice

This is the reason people underestimate, because it sounds like a preference and it is actually law.

Beta-lactam antibiotics must be manufactured in physically segregated premises. Not a separate line — separate premises, separate air handling. Ophthalmics and injectables require sterile manufacturing. Ayurvedic products are licensed under an entirely different Act.

So a company owning a general tablet and capsule plant, selling a broad range, is not choosing whether to outsource. Its own site certificate decides for it. If it wants an antibiotic, an eye drop and an injectable in the range, those come from three other places. There is no version of this where one plant covers everything.

Which is why the honest question was never "do you own a plant." It is which forms do you own, and where does the rest come from.

2. Peaks are rented; capacity is bought

Demand moves. Anti-cold and anti-allergic ranges swing hard by season. A plant sized for the winter peak is half-empty by April, and every idle hour costs the same overheads as a busy one.

So established companies run their own lines at steady base load and push the peaks outward. You buy the capacity you always need and rent the capacity you sometimes need. That is not weakness — it is the correct shape.

3. Testing a product without occupying your own line

A new product on your own plant costs a validated line, a stability programme, and floor space that could have made a proven earner. Outsourcing the trial means a failed product costs one batch, and your own capacity stays on the products that already work.

Large companies protect their own lines for their winners. That is what the outsourcing budget is actually for.

What good outsourcing discipline looks like

• Certificate before rate, on every partner, every time.
• Know whose licence each product is made under — it is on your own pack.
• Batch record and COA as standard, not on request.
• Know who else that plant serves. A plant audited by several pharmaceutical customers cannot quietly deprioritise you. This is the month-nine test.
• Never outsource a form the site is not certified for, whatever anyone promises.

The thing nobody says out loud

Since almost every company outsources part of its range, the industry's favourite boast — "we have our own WHO-GMP facility" — is true and incomplete for nearly everyone saying it.

It is not a lie. It is just not the whole picture. The useful version is: we own this site, certified for these forms; everything else comes from these other certified sites. Almost nobody publishes that second sentence. The structural reasons behind all of it are here.

Who manufactures for Vibcare

We will apply our own rule to ourselves. Vibcare Pharma is a PCD pharma franchise company. It does not manufacture. Manufacturing is done by Vibcare Healthcare Private Limited — a separate company under the same ownership, with its own plant, licences and website.

The site: Khasra No. 6/2/2, Kota Road, Dabkori, Panchkula 134103, Haryana. WHO-GMP certified by the State Drugs Controller-cum-Licensing Authority, FDA Haryana. Site Certificate No. 1/182-1Drug-I-2024, issued 24 October 2024. Licences MLF252023HR000004 and MLF282023HR000005, valid to 7 May 2028. 100,000 sq ft clean room, 750+ drug approvals.

What that site is certified for: tablets, capsules and external preparations — all non beta-lactam — and oral liquids. What it is not, and therefore where we outsource: beta-lactam antibiotics, ophthalmics, injectables, softgels, IV liquids, respules, DPI, nasal sprays, protein powders and sachets, and ayurvedic products — all made at other WHO-GMP certified sites we do not own.

That is the second sentence, published. Ask anyone else on your shortlist for theirs.

Not manufacturing at all? A PCD pharma franchise — monopoly territory, ready range, from ₹25,000. Here is the difference.

Frequently asked questions

Why do pharma companies with their own plants still outsource production?

Because regulation forces it. Beta-lactams need physically segregated premises, sterile forms need sterile lines, and ayurvedic products are licensed separately. A company with a general tablet plant selling a broad range must source those forms elsewhere. They also rent seasonal peaks rather than build for them.

What are the benefits of outsourcing pharma production?

You cover dosage forms your own site is not certified for, meet seasonal peaks without building for them, and test new products without occupying your own validated lines. Established companies protect their own capacity for proven earners and outsource the rest.

Can a pharma company manufacture its entire range in one plant?

No. Beta-lactam antibiotics require physically segregated premises by regulation; ophthalmics and injectables need sterile manufacturing; ayurvedic products fall under a separate Act. Any company implying one facility covers a broad range is describing something that does not exist — ask which site each dosage form comes from.

How should an established company manage outsourced manufacturing?

Certificate before rate on every partner. Know whose licence each product is made under. Insist on batch records and certificates of analysis as standard. Find out who else audits that plant. And never outsource a dosage form the site is not certified for, whatever is promised.